05:33 PM EDT, 10/15/2025 (MT Newswires) -- Jared Gollob, Chief Medical Officer, on October 15, 2025, sold 59,576 shares in Kymera Therapeutics ( KYMR ) for $3,659,254. Following the Form 4 filing with the SEC, Gollob has control over a total of 109,992 common shares of the company, with 109,992 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1815442/000119312525240430/xslF345X05/ownership.xml